The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Topiramate in essential tremor: A double-blind, placebo-controlled trial
Abstract
BACKGROUND: Essential tremor is most prevalent and most disabling in older patients. Additional therapies are required for patients with an inadequate response or intolerable side effects. In small trials, topiramate appeared to be beneficial in essential tremor. METHODS: In this multicenter, double-blind, placebo-controlled, parallel-design trial, patients with moderate to severe essential tremor of the upper limbs were randomized to 24 weeks of treatment with placebo or topiramate (target dose, 400 mg/day) as monotherapy or as an adjunct to one antitremor medication. The primary efficacy variable was the final visit tremor score based on the Fahn-Tolosa-Marin Tremor Rating Scale (TRS). RESULTS: The intent-to-treat population was 208 patients (topiramate, 108; placebo, 100). The final visit score (last observation carried forward) was lower in the topiramate group than with placebo (p < 0.001). Mean percentage improvement in overall TRS scores was 29% with topiramate at a mean final dose of 292 mg/day and 16% with placebo (p < 0.001). Topiramate was associated with greater improvement in function and disability (p = 0.001). A between-group difference (p < 0.001) was observed at the first on-treatment visit at 4 weeks when the target topiramate dose was 100 mg/day (mean achieved dose, 62 +/- 9 mg/day). The most common treatment-limiting adverse events in topiramate-treated patients were paresthesia (5%), nausea (3%), concentration/attention difficulty (3%), and somnolence (3%). Adverse events were treatment limiting in 31.9% of topiramate patients and 9.5% of placebo patients. CONCLUSIONS: Topiramate was effective in the treatment of moderate to severe essential tremor. Tremor reduction was accompanied by functional improvements, such as in motor tasks, writing, and speaking.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Louis, E. D., Ottman, R., & Allen Hauser, W. (1998) · Movement Disorders · doi:10.1002/mds.870130105 · Cited by 424
Acute and chronic effects of propranolol and primidone in essential tremor
Koller, W. C., & Vetere-Overfield, B. (1989) · Neurology · doi:10.1212/wnl.39.12.1587 · Cited by 198
Self-citationEssential tremor frequency decreases with time
Elble, R. J. (2000) · Neurology · doi:10.1212/wnl.55.10.1547 · Cited by 166
Self-citation
Cited by
Treatment of patients with essential tremor
Deuschl, G., Raethjen, J., Hellriegel, H., & Elble, R. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70322-7 · Cited by 428
Self-citationZesiewicz, T. A., Elble, R. J., Louis, E. D., Gronseth, G. S., Ondo, W. G., Dewey, R. B., Okun, M. S., Sullivan, K. L., & Weiner, W. J. (2011) · Neurology · doi:10.1212/wnl.0b013e318236f0fd · Cited by 348
Self-citationStacy, M. A., Elble, R. J., Ondo, W. G., Wu, S., Hulihan, J., & TRS Study Group (2007) · Movement Disorders · doi:10.1002/mds.21412 · Cited by 296
Self-citationEssential tremor: emerging views of a common disorder
Benito-León, J., & Louis, E. D. (2006) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0347 · Cited by 295
Treatment of hyperkinetic movement disorders
Jankovic, J. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70183-8 · Cited by 252
Self-citation
Metadata
- Authors
- Ondo, W. G., Jankovic, J., Connor, G. S., Pahwa, R., Elble, R., Stacy, M. A., Koller, W. C., Schwarzman, L., Wu, S. C., & Hulihan, J. F.
- Venue
- Neurology
- Published
- 2006-03-14
- Volume
- 66
- Issue
- 5
- Pages
- 672-677
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2011248696
- Cited by
- 174
- References
- 3
- FWCI
- 9.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Topiramate in essential tremor: A double-blind, placebo-controlled trial. https://app.cochat.ai/papers/10.1212/01.wnl.0000200779.03748.0f
- The paper
- Ondo, W. G., Jankovic, J., Connor, G. S., Pahwa, R., Elble, R., Stacy, M. A., Koller, W. C., Schwarzman, L., Wu, S. C., & Hulihan, J. F. (2006). Topiramate in essential tremor: A double-blind, placebo-controlled trial. Neurology. https://doi.org/10.1212/01.wnl.0000200779.03748.0f
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.